{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:15:30Z","timestamp":1777896930065,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016857","name":"CVPath Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018878","name":"OrbusNeich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012052","name":"Race Forward","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.iccl.2025.12.001","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:37:00Z","timestamp":1770151020000},"page":"191-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathophysiology of Coronary Restenosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Kazuhiro","family":"Fujiyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.iccl.2025.12.001_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"9710","key":"10.1016\/j.iccl.2025.12.001_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.iccl.2025.12.001_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2020.08.002","article-title":"Trends and outcomes of restenosis after coronary stent implantation in the United States","volume":"76","author":"Moussa","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.iccl.2025.12.001_bib5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.iccl.2025.12.001_bib6","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.iccl.2025.12.001_bib7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"10.1016\/j.iccl.2025.12.001_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jcin.2015.04.032","article-title":"Drug-coated balloons versus second-generation drug-eluting stents for the management of recurrent multimetal-layered in-stent restenosis","volume":"8","author":"Kawamoto","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-018-1076-6","article-title":"Refractory in-stent restenosis: improving outcomes by standardizing our approach","volume":"20","author":"Waksman","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.001_bib11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1253\/circj.70.1026","article-title":"Myocardial infarction as a presentation of clinical in-stent restenosis","volume":"70","author":"Nayak","year":"2006","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.001_bib12","first-page":"401","article-title":"Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era","volume":"20","author":"Michael","year":"2008","journal-title":"J Invasive Cardiol"},{"issue":"14","key":"10.1016\/j.iccl.2025.12.001_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12928-013-0179-7","article-title":"Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the randomized evaluation of sirolimus-eluting versus Everolimus-eluting stent trial (RESET)","volume":"28","author":"Kozuma","year":"2013","journal-title":"Cardiovasc Interv Ther"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002223","article-title":"Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents","volume":"8","author":"Piccolo","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2025.12.001_bib16","article-title":"First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients","volume":"1","author":"Navarese","year":"2014","journal-title":"Open Hear"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.001_bib17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants: bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.001_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007244","article-title":"Very late pathological responses to cobalt-chromium everolimus- eluting, stainless steel sirolimus-eluting, and cobalt-chromium bare metal stents in humans","volume":"6","author":"Mori","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.iccl.2025.12.001_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/14779072.2021.1856657","article-title":"Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges","volume":"19","author":"Sakamoto","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.iccl.2025.12.001_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2021.08.007","article-title":"Autoimmune diseases in patients undergoing percutaneous coronary intervention: a risk factor for in-stent restenosis?","volume":"333","author":"Pepe","year":"2021","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.001_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(01)01646-0","article-title":"An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions","volume":"88","author":"Morino","year":"2001","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.001_bib24","first-page":"873","article-title":"Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-everolimus-and sirolimus-eluting stent implantation","volume":"83","author":"Song","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.iccl.2025.12.001_bib25","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","article-title":"Morphological predictors of restenosis after coronary stenting in humans","volume":"105","author":"Farb","year":"2002","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.iccl.2025.12.001_bib26","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000069943.41206.BD","article-title":"Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken","volume":"107","author":"Shah","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.001_bib27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mabi.201000509","article-title":"Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia","volume":"11","author":"Serrano","year":"2011","journal-title":"Macromol Biosci"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.001_bib28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.001_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1755-5922.2010.00155.x","article-title":"In-stent restenosis","volume":"29","author":"Kim","year":"2011","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.001_bib30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0735-1097(92)90389-5","article-title":"The restenosis paradigm revisited: an alternative proposal for cellular mechanisms","volume":"20","author":"Schwartz","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib31","first-page":"173","article-title":"Treatment of coronary in-stent restenosis: a systematic review","volume":"15","author":"Pleva","year":"2018","journal-title":"J Geriatr Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1253\/circj.CJ-18-0701","article-title":"Different neoatherosclerosis patterns in drug-eluting - and bare-metal stent restenosis: optical coherence tomography study","volume":"83","author":"Nakamura","year":"2019","journal-title":"Circ J"},{"issue":"42","key":"10.1016\/j.iccl.2025.12.001_bib33","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1093\/eurheartj\/eht241","article-title":"Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics","volume":"34","author":"Nakano","year":"2013","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.iccl.2025.12.001_bib34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.amjcard.2009.12.064","article-title":"Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis","volume":"105","author":"Kang","year":"2010","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.iccl.2025.12.001_bib35","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/ATVBAHA.113.301659","article-title":"Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-\u03b1 activation and disruption of the p120-vascular endothelial cadherin interaction","volume":"33","author":"Habib","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.iccl.2025.12.001_bib36","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/ATVBAHA.118.311321","article-title":"Direct targeting of the mTOR (mammalian target of rapamycin) kinase improves endothelial permeability in drug-eluting stents-brief report","volume":"38","author":"Harari","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.001_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrcardio.2013.13","article-title":"New concepts in the design of drug-eluting coronary stents","volume":"10","author":"Garg","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/clc.24139","article-title":"Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: a systematic review and meta-analysis","volume":"46","author":"Li","year":"2023","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-85740-2","article-title":"Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model","volume":"11","author":"Migita","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.001_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12350-010-9218-2","article-title":"Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: a meta-analysis","volume":"17","author":"Carrabba","year":"2010","journal-title":"J Nucl Cardiol [Internet]"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0284185118774956","article-title":"Diagnostic accuracy of dual-source and 320-row computed tomography angiography in detecting coronary in-stent restenosis: a systematic review and meta-analysis","volume":"60","author":"Liu","year":"2019","journal-title":"Acta radiol"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.001_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/RLI.0b013e3181dfa312","article-title":"Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosis","volume":"45","author":"de Graaf","year":"2010","journal-title":"Investig Radiol"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10554-015-0826-4","article-title":"Assessment of coronary in-stent restenosis: value of subtraction coronary computed tomography angiography","volume":"32","author":"Amanuma","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.iccl.2025.12.001_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejrad.2019.04.011","article-title":"Diagnostic performance of fractional flow reserve derived from coronary CT angiography for detection of lesion-specific ischemia: a multi-center study and meta-analysis","volume":"116","author":"Tang","year":"2019","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjcard.2007.03.076","article-title":"Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI)","volume":"100","author":"Escolar","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.001_bib46","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jvsv.2021.04.016","article-title":"Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: a systematic review and meta-analysis","volume":"9","author":"Karathanos","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation","volume":"59","author":"Tearney","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1253\/circj.CJ-16-1069","article-title":"Difference of tissue characteristics between early and late restenosis after second-generation drug-eluting stents implantation \u2015 an optical coherence tomography study","volume":"81","author":"Jinnouchi","year":"2017","journal-title":"Circ J"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.001_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ehjci\/jew198","article-title":"Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis","volume":"18","author":"Roleder","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.001_bib50","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.001_bib52","first-page":"1080","article-title":"Management of drug eluting stent in-stent restenosis: a systematic review and meta-analysis","volume":"87","author":"Goel","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.iccl.2025.12.001_bib53","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcin.2012.03.017","article-title":"Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis: results from a prospective multicenter study (RIBS III [restenosis intra-stent: balloon angioplasty versus drug-eluting stent])","volume":"5","author":"Alfonso","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.001_bib54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE Randomized Clinical Trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.iccl.2025.12.001_bib55","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2025.12.001_bib56","first-page":"1","article-title":"Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients","volume":"351","author":"Giacoppo","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.iccl.2025.12.001_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2017.11.076","article-title":"Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: a pooled analysis of the intracoronary stenting and angiographic results: optimizing treatment of drug eluting stent in","volume":"252","author":"Colleran","year":"2018","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.001_bib58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0195-668X(02)00202-6","article-title":"Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques","volume":"24","author":"Radke","year":"2003","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.001_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM200101253440402","article-title":"Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting","volume":"344","author":"Leon","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.001_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","article-title":"Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review","volume":"12","author":"Shlofmitz","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.001_bib61","first-page":"105","article-title":"Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge","volume":"5","author":"Borovac","year":"2019","journal-title":"Eur Heart J"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745825001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745825001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:41:48Z","timestamp":1777624908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745825001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2211745825001026"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2025.12.001","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of Coronary Restenosis","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}